Aaron Janowsky

Oregon Health & Science University — United States

Neuroscience · Life Sciences

49h-index6.8kcitations160works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neurotransmitter Receptor Influence on Behavior(62), Neuroscience and Neuropharmacology Research(62), Receptor Mechanisms and Signaling(53), Cannabis and Cannabinoid Research(15), Neuropeptides and Animal Physiology(11)

Publications160 total

Specific GPCRs Elicit Unique Extracellular Vesicle MiRNA Array Signatures: An Exploratory Study
2026Open Access
Evaluation of the Relationship between Vesicular Monoamine Transporter 2 (VMAT2) Inhibition and Neurologic Adverse Events in Approved Drugs
ACS Pharmacology & Translational Science·2025Open Access
Combining the alpha-2 adrenergic agonist clonidine with naloxone rescues fentanyl-induced physiologic dysfunction and increases survival
2025Open Access
Specific GPCRs Elicit Unique Extracellular Vesicle MiRNA Array Signatures: An Exploratory Study
2025Open Access
Specific GPCRs Elicit Unique Extracellular Vesicle MiRNA Array Signatures: An Exploratory Study
2025Open Access
Author response: Specific GPCRs Elicit Unique Extracellular Vesicle MiRNA Array Signatures: An Exploratory Study
2025Open Access
Trace amine–associated receptor 1 agonists differentially regulate dopamine transporter function
Molecular Pharmacology·2025· 1 citedOpen Access
Specific GPCRs Elicit Unique Extracellular Vesicle MiRNA Array Signatures: An Exploratory Study
2025Open Access
New Genetic and Pharmacological Approaches to Dissect Central Versus Peripheral Dopamine Receptor Signaling in Metabolic Regulation: A Novel Perspective in Metabolic Psychiatry
Biological Psychiatry·2025
Pharmacological Characterization of New Psychoactive Substance (NPS) Designer Benzodiazepines (BZDs) (Abstract ID: 192524)
Journal of Pharmacology and Experimental Therapeutics·2025
Binding Affinity and Functional Activity of 24 Emerging Cannabinoids at the CB1 Receptor and Safety-Related Targets
Drug and Alcohol Dependence·2025· 1 cited
Validation of a Noninvasive Method for Monitoring the Effect of Synthetic Opioids on Vocal Cord Activity Using Piezoelectric Sensors
Drug and Alcohol Dependence·2025
Pharmacological Characterization of Substituted Nitazenes at Opioid Receptors
Drug and Alcohol Dependence·2025
Pharmacology of Newer Synthetic Cannabinoids at the CB1 Receptor
Drug and Alcohol Dependence·2025
Pharmacological and Physiological Differences between Synthetic Opioids and Morphine at the Upper Airway
Drug and Alcohol Dependence·2025· 1 cited
Development of Novel Tools for Dissection of Central Versus Peripheral Dopamine D2-Like Receptor Signaling in Dysglycemia
Diabetes·2024· 5 cited
Pharmacologic Characterization of Substituted Nitazenes at μ, κ, and Δ Opioid Receptors Suggests High Potential for Toxicity
Journal of Pharmacology and Experimental Therapeutics·2024· 25 citedOpen Access
Development of novel tools for dissection of central versus peripheral dopamine D <sub>2</sub> -like receptor signaling in dysglycemia
2024Open Access
MicroRNA137-loaded lipid nanoparticles regulate synaptic proteins in the prefrontal cortex
Molecular Therapy·2023· 16 citedOpen Access
Monoacylglycerol Lipase Protects the Presynaptic Cannabinoid 1 Receptor from Desensitization by Endocannabinoids after Persistent Inflammation
Journal of Neuroscience·2023· 10 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Amy J. Eshleman(15), Kim A. Neve(10), Phil Skolnick(8), Katherine M. Wolfrum(7), Robert A. Johnson(6), Steven M. Paul(6), Fridolin Sulser(5), John F. Reed(5), Paul Berger(4), Tamara J. Phillips(4), Jennifer M. Loftis(3), Frank J. Vocci(3), Randy Torralva(3), Margaret M. Schweri(3), Piotr Popik(3), Arnold Lippa(3), Charles K. Meshul(3), Barry Taylor(3), Tracy L. Swanson(3), John K. Belknap(3)